All news from Anaesthesiology

Deadly Bacteria: Immunotherapy Against These Pathogens

Researchers have designed a strategy aimed at tagging Gram-negative bacteria for destruction via small molecule conjugates they have created that specifically home to bacterial cell surfaces and trigger an immune response. They observed a significant decrease in the number of live bacteria using their compound in experiments on E. coli in human serum.

New Drug Can Restore Hearing By Gene Editing In Inner Ear

According to a new study, researchers examine that a new drug could restore hearing by 'turning on' genes that keep vital hair cells in the inner ear alive. The study shows that a particular kind of genetic deafness, called DFNA27, can be reversed using a molecular drug that 'acts like a switch' for deafness. The study was published in Cell

New drug could restore hearing by 'turning on' genes that keep hair cells alive

1. Scientists discover faulty DFNA27 gene can be fixed by introducing a drug

2. They were able to partially restore hearing in mice

3. Similar approaches might work for the inherited progressive hearing loss

4. Deafness has genetic causes in more than 50% of people and is incurable

Examine The Prevalance Of Obesity Among Traumatic Brain Injury Patients

A study determines that especially at longer follow-up times, overweight and obesity are associated with chronic disease risks for survivors of moderate to severe traumatic brain injury (TBI). The study was published in the Journal of Head Trauma Rehabilitation (JHTR).

Examine the prevalence of weight classifications and factors related to obesity/overweight among persons 1 to 25 years following traumatic brain injury (TBI) using the Traumatic Brain Injury Model Systems national database.

New Hope For People With Disabling Dupuytren's Disease

Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for the progression of Dupuytren's disease

Zephyr Endobronchial Valve Approved to Treat Severe Emphysema

Pulmonx® Corp. announced that the U.S. Food and Drug Administration (FDA) has approved the Zephyr® Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the first minimally-invasive device approved in the United States for treating patients with severe emphysema, a progressive and life-threatening form of the chronic obstructive pulmonary disease (COPD).

New Method To Deliver Better Care For End-Of-Life Patients

Researchers have shown that seriously ill and frail hospitalized patients are frequently subjected to unnecessary, invasive procedures that do not enhance the quality of life. Surveys amongst seriously ill hospitalized patients have identified the better end of life planning as an area of potential improvement for hospitals

The level of communication between patient and physician can make a monumental difference, specifically in the case of seriously ill hospitalized patients. Researchers at the University of Minnesota have found a way to better identify these patients with the hopes of the better facilitating "end-of-life" or specialized conversations and care.

New Approaches to Avoid Infection Transmission in Clinical Settings

The medical community is losing its biggest gun in fighting infection, antibiotics. Researchers are turning to safety protocols to reduce the transmission of antibiotic-resistant organisms, like Clostridium difficile, methicillin-resistant Staphylococcus aureus(MRSA) and influenza. The healthcare environment, however, may be setting health care workers up for failure.